Moxipraquine
CAS No. 23790-08-1
Moxipraquine( —— )
Catalog No. M36200 CAS No. 23790-08-1
Moxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 246 | Get Quote |
|
| 5MG | 371 | Get Quote |
|
| 10MG | 561 | Get Quote |
|
| 25MG | 868 | Get Quote |
|
| 50MG | 1178 | Get Quote |
|
| 100MG | 1557 | Get Quote |
|
| 500MG | 3114 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMoxipraquine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMoxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs.
-
DescriptionMoxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs. Moxipraquine was effective against experimental infections of Leishmania major, Lactobacillus mexicanus, and Lactobacillus brasiliensis, but was Ineffective.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23790-08-1
-
Formula Weight414.58
-
Molecular FormulaC24H38N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(CCCCCCN1CCN(CCC(C)O)CC1)C=2C3=C(C=C(OC)C2)C=CC=N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Neomycin Sulphate B
Neomycin belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.
-
Golotimod
Golotimod (SCV 07) is an antimicrobial dipeptide with immunomodulatory activity that significantly improves the efficacy of anti-tuberculosis therapy.
-
Cefuzonam
Cefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.
Cart
sales@molnova.com